Navigation Links
DNA Vaccine Trials Against HIV Virus In Sweden Nurture Hope

Swedish researchers have expressed hope regarding the DNA vaccine trials conducted against the AIDS/HIV virus. The first phase of the clinical trials have already been completed among 40 HIV- negative // volunteers.

DNA vaccines represent the latest innovation in the area of vaccine biology. It involves direct injection of one or more genes coding for specific antigens into the human body. These vaccines precipitate an immune response so that the body's defense mechanism recognize and destroy the virus once it enters the living system.

'The technology is highly promising for producing simple, inexpensive and heat-stable vaccines,' according to health experts at International AIDS Vaccine Initiative (IAVI).

Although the study is not yet over, the researchers are very positive about the outcome of the clinical trial. 'There is every reason to be hopeful, even though the study is not finished,' said Professor Britta Wahren who developed the vaccine. Furthermore, no vaccine related side effects have been documented so far.

The second phase trial, targeted at testing the effectiveness of the vaccine to enhance the immune response, is due to end next May or June. The third phase of the clinical trial is hoped to take place in Tanzania. The ability of the vaccine to limit the effects of the virus in HIV infected persons would be tested in the thrid phase.

Clinical trials for new vaccines undergo three phases of intensive research work before it can be marketed for commercial use. The prospective vaccine is being tested on a small group of volunteers to assess the safety and efficacy in the first phase. Followed by successful completion of this phase, it moves on the second and third phase where it goes through progressively wider trials, among thousands of volunteers.

More than 30 candidate AIDS vaccines are currently being tested worldwide. The increased financial grants for AIDS is said to have promp ted for this global competition.

Detractors have raised skeptical concerns regarding the materialization of a DNA vaccine for HIV infection. The situation though seems promising with such clinical trials reporting success from time to time.


'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 22, ... ... surgeries take place each year with the majority of patients not requiring pain ... American Orthopaedic Society for Sports Medicine’s Annual Meeting today in Toronto, Ontario, ...
(Date:7/21/2017)... ... 2017 , ... The Wettstein Agencies, a central Colorado firm ... Denver region, is announcing a charity drive to help raise support for Dominik, ... , Until a few months ago, Dominik was a healthy and happy young ...
(Date:7/21/2017)... Minnesota (PRWEB) , ... July 21, 2017 , ... ... BWBR recently were selected to renovate and improve the Ramsey County Medical Examiners ... adjacent to Regions Hospital, the $2.5 million project is scheduled to start in ...
(Date:7/21/2017)... ... July 21, 2017 , ... Bernard R. Bach, Jr., MD, orthopaedic ... American Orthopaedic Society of Sports Medicine (AOSSM) , received the 2017 Robert E. ... Meeting in Toronto, Canada. This prestigious award is given annually to honor those who ...
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ ... their chances of acceptance to a residency in a United States hospital. Being ... outside the U.S. , According to data released by the ECFMG®, every year, ...
Breaking Medicine News(10 mins):
(Date:7/1/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced ... broadcast live over the Internet on Thursday, July 27, 2017, ... quarterly results will be made available at 7:30 a.m. Eastern ... live audio webcast can be accessed via Zimmer Biomet,s Investor ... for replay following the conference call. ...
(Date:6/30/2017)... June 29, 2017  Axium Pharmaceuticals Inc. is a pharmaceutical company ... formulations and alternative dosage forms of existing biologically active molecule. ... ... our waterless self-nano emulsifying formula, which is designed to prevent ... believe the spray will provide fast onset of action and ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: